Trial Profile
Pan-genotypic combination trial of samatasvir and IDX 21437 for the treatment of chronic hepatitis C
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2014
Price :
$35
*
At a glance
- Drugs Samatasvir (Primary) ; Uprifosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Idenix Pharmaceuticals
- 27 Feb 2014 New trial record